source
- Merck secures US approval for the first oral PCSK9 cholesterol-lowering pill, edging out AstraZenecaMerck has received the United States regulatory clearance for an oral PCSK9 inhibitor, marking the first time a pill of this class has been approved for cholesterol management. The approval comes…
- UnitedHealth beats Q2 forecasts but warns rising insurance costs will strain employersUnitedHealth Group reported second-quarter results that exceeded analysts' expectations, lifting its shares modestly. Despite the upbeat earnings, executives highlighted that medical expenses for…